Breadcrumb

null Timothy Wideman honoured by Arthritis Society of Canada

An RI-MUHC investigator has been recognized for his research on sensitivity to pain from physical activity

SOURCE: Health e-News and RI-MUHC
​​​​​​​March 12, 2024

Timothy Wideman, PhD, Associate Professor, School of Physical and Occupational Therapy, McGill University, and Investigator at the Research Institute of the McGill University Health Centre (RI-MUHC), was recognized for his research on sensitivity to pain from physical activity by being named to Arthritis Society Canada’s Top 10 Research Advances of 2023. At the RI-MUHC, Wideman is an investigator in the Surgical and Interventional Sciences Program and conducts research at the Centre for Outcomes Research and Evaluation.

Managing back pain

Wideman identified a molecular sign of inflammation in the saliva of people with back pain that can distinguish who might experience more pain from physical activity, which is usually recommended to reduce joint pain.

A new assessment tool based on pain experienced during tasks can also give a better picture of the impact of this sensitivity on pain and mood in daily life, compared to traditional pain questionnaires. These insights can help physical therapists and other health and exercise professionals to develop and prescribe more personalized physical activity programs or routines to help effectively manage pain in daily life for people with back pain.

Timothy Wideman, PhD, is an investigator in the Surgical and Interventional Sciences Program and Centre for Outcomes Research and Evaluation at the RI-MUHC
Timothy Wideman, PhD, is an investigator in the Surgical and Interventional Sciences Program and Centre for Outcomes Research and Evaluation at the RI-MUHC

​​​​​​​Improving people’s quality of life
​​​​​​​

​​​​​​​“Given the impact on patients, the healthcare system and society at large, research is critical to transforming how arthritis is diagnosed, treated and prevented, and ensuring people receive the best possible care to improve the quality of their lives,” said Dr. Siân Bevan, Chief Science Officer at Arthritis Society Canada, in the organization’s press release.​​​​​​

 

Arthritis Society Canada is a national health charity supporting arthritis research, advocacy, and innovation. Arthritis Society Canada is the nation’s largest charitable funder of arthritis research. Last year, the organization invested in $6.2 million in research to bring transformational impact to the six million people in Canada living with arthritis.

View the full list of Arthritis Society Canada’s Top 10 Research Advances of 2023.

—First published Feb. 22, 2024, by McGill Reporter staff